---
title: "Healthcare Disinfectant and Sanitizer Market, Global Outlook and Forecast 2025-2032"
datePublished: Thu Aug 28 2025 19:28:19 GMT+0000 (Coordinated Universal Time)
cuid: cmevsqwtw000902lb041t5fdo
slug: healthcare-disinfectant-and-sanitizer-market-global-outlook-and-forecast-2025-2032

---

# Healthcare Disinfectant and Sanitizer Market, Global Outlook and Forecast 2025-2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global healthcare disinfectant and sanitizer market size was valued at USD 6.94 billion in 2024. The market is projected to grow from USD 7.65 billion in 2025 to USD 12.48 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/228419/healthcare-disinfectant-and-sanitizer-market">
            https://www.24chemicalresearch.com/download-sample/228419/healthcare-disinfectant-and-sanitizer-market</a></b></div><br><p>
</p><p>Healthcare disinfectants are chemical agents designed to destroy pathogenic microorganisms on surfaces and medical equipment, while sanitizers are substances that reduce microbial contamination to safe levels. These products include alcohol-based formulations, quaternary ammonium compounds, chlorine compounds, hydrogen peroxide solutions, and other specialized antimicrobial agents crucial for infection prevention in clinical settings.</p><p>
</p><p>The market growth is primarily driven by increasing healthcare-associated infection (HAI) rates, with approximately 7% of hospitalized patients in developed countries acquiring at least one HAI according to recent data. Heightened awareness of hospital hygiene protocols post-pandemic and stringent regulatory requirements for healthcare facilities are accelerating product adoption. Major industry players like 3M and Ecolab have recently introduced advanced hydrogen-peroxide-based disinfectants with shortened contact times, addressing the growing demand for rapid yet effective solutions in busy healthcare environments.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Rising Healthcare-Associated Infections Driving Demand for Effective Disinfectants</strong></p><p>
</p><p>The global healthcare disinfectant and sanitizer market is experiencing substantial growth due to the increasing prevalence of healthcare-associated infections (HAIs). Recent data indicates that over 4 million patients in Europe alone acquire HAIs annually, creating urgent demand for advanced disinfection solutions. Hospitals and clinics are prioritizing robust infection control protocols, with disinfectants accounting for approximately 68% of all infection prevention product purchases in 2024. This trend is particularly pronounced in surgical environments, where 92% of facilities now implement terminal room disinfection between procedures.</p><p>
</p><p style="text-align:center"><strong>Pandemic-Driven Behavioral Shifts Sustaining Market Growth Post-COVID</strong></p><p>
</p><p>While the initial surge in demand during the COVID-19 pandemic has normalized, sustained behavioral changes continue to benefit the market. Consumer surveys from Q1 2025 reveal that 78% of households maintain sanitizing habits developed during the pandemic, with 63% of respondents using hand sanitizers daily. Commercial establishments have institutionalized these practices, with 82% of businesses in North America reporting continued investment in surface disinfection systems. Major retailers now allocate 15-20% of facility maintenance budgets to antimicrobial solutions, creating stable demand through 2032.</p><p>
</p><p style="text-align:center"><strong>Technological Advancements in Formulations Creating Premium Product Segments</strong></p><p>
</p><p>Innovation in antimicrobial chemistry is driving market segmentation and premiumization. Newer fourth-generation quaternary ammonium compounds demonstrate 43% greater efficacy against drug-resistant pathogens compared to traditional formulas. The hospital-grade disinfectant segment is projected to grow at 7.8% CAGR through 2032, fueled by products like enzymatic cleaners that combine cleaning and disinfection. Recent product launches featuring extended residual protection (up to 30 days on surfaces) are commanding 25-30% price premiums while reducing application frequency by 40%.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Regulatory Complexities Creating Barriers to Product Innovation</strong></p><p>
</p><p>Stringent regulatory frameworks are significantly impacting product development cycles in the disinfectant market. The average EPA registration process now takes 18-24 months for new formulations, with approval costs exceeding $500,000 per product. In the EU, upcoming revisions to the Biocidal Products Regulation (BPR) may eliminate 15% of currently approved active ingredients by 2026. These regulatory hurdles have already led to 22% reduction in new antimicrobial product launches between 2022-2024 compared to the previous three-year period.</p><p>
</p><p style="text-align:center"><strong>Price Volatility of Raw Materials Impacting Manufacturer Margins</strong></p><p>
</p><p>The industry faces operational challenges from fluctuating raw material costs, particularly for key ingredients like isopropyl alcohol and hydrogen peroxide. In 2024, isopropyl alcohol prices reached $1,950/MT, representing a 120% increase from pre-pandemic levels. This volatility has compressed gross margins for mid-sized manufacturers to 18-22%, down from industry-standard 30-35% margins. Many producers are now reformulating products with alternative active ingredients, though this process requires significant R&amp;D investment and regulatory re-certification.</p><p>
</p><p style="text-align:center"><strong>Growing Consumer Skepticism Toward Chemical Disinfectants</strong></p><p>
</p><p>Increasing environmental and health concerns are creating resistance to traditional chemical disinfectants, particularly in consumer markets. Recent studies show 45% of European consumers actively avoid products containing quaternary ammonium compounds due to safety concerns, while 38% of North American parents restrict antimicrobial product use around children. This sentiment has propelled the natural disinfectant segment to 12% annual growth, though these products still represent less than 8% of the total market due to efficacy limitations against resistant pathogens.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Emerging Markets Present Untapped Growth Potential</strong></p><p>
</p><p>Developing healthcare infrastructure in APAC and MEA regions offers substantial expansion opportunities. India's hospital disinfection market is projected to grow at 11.4% CAGR through 2032, driven by government initiatives to reduce HAI rates below 5%. Similarly, Middle Eastern countries are implementing mandatory disinfection protocols, with Saudi Arabia requiring all healthcare facilities to use EPA-certified products by 2026. These markets currently have disinfectant penetration rates 35-40% below Western counterparts, representing significant unmet demand.</p><p>
</p><p style="text-align:center"><strong>Smart Disinfection Systems Opening New Application Areas</strong></p><p>
</p><p>The integration of IoT and automation in disinfection is creating premium market segments. UV-C disinfection robots now account for 18% of hospital capital equipment budgets, with adoption growing at 28% annually. Next-generation systems combining UV with hydrogen peroxide vapor demonstrate 6-log reduction against C. difficile while reducing disinfection time by 65%. These advanced solutions command 3-5x price premiums over conventional products and are expanding into non-healthcare verticals like public transit and education.</p><p>
</p><p style="text-align:center"><strong>Sustainability Initiatives Driving Green Chemistry Innovation</strong></p><p>
</p><p>Environmental sustainability has become a key product differentiator, with 62% of procurement managers considering eco-certifications in purchasing decisions. Bio-based disinfectants using plant-derived actives are gaining traction, though currently priced 40-50% higher than conventional alternatives. The antimicrobial coatings segment, valued at $3.2 billion in 2024, is particularly active in sustainable innovation with products delivering up to 90 days of residual protection using silver ion technology. Regulatory support through green chemistry initiatives is expected to accelerate this segment's growth to $5.8 billion by 2032.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Antimicrobial Resistance Threatening Product Efficacy</strong></p><p>
</p><p>The rapid development of pathogen resistance poses existential challenges for disinfectant manufacturers. Recent studies indicate 23% of hospital MRSA isolates now show reduced susceptibility to quaternary ammonium compounds, historically the most widely used disinfectant class. This has forced product reformulations and rotation protocols, increasing operational complexity for healthcare facilities. The industry faces mounting pressure to develop next-generation actives, though R&amp;D timelines for novel antimicrobials typically exceed five years.</p><p>
</p><p style="text-align:center"><strong>Supply Chain Vulnerabilities Impacting Market Stability</strong></p><p>
</p><p>Global supply chain disruptions continue to affect disinfectant availability, particularly for alcohol-based products. The 2024 Taiwan earthquake severely impacted isopropanol production, causing 30-45 day delivery delays across Asia. Similarly, shipping container shortages have increased trans-Pacific freight costs by 220% since 2020. These disruptions have prompted 68% of manufacturers to implement regional production strategies, though localization efforts require $5-10 million capital investments per facility.</p><p>
</p><p style="text-align:center"><strong>Workforce Shortages Affecting Service-Based Disinfection Models</strong></p><p>
</p><p>The growing market for contract disinfection services faces labor availability challenges. The U.S. environmental services sector reports 22% vacancy rates for trained technicians, leading to 15-20% service premium pricing. This shortage is particularly problematic for terminal cleaning services, where proper technique is critical for infection control. Training new technicians requires 80-120 hours of instruction, creating implementation bottlenecks as demand grows 18% annually in the healthcare sector alone.</p><p>

<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Disinfectants Segment Leads the Market Due to Rising Demand for Infection Control in Healthcare Facilities</strong></p><p>
</p><p>The market is segmented based on type into:</p><p>
</p><p>Disinfectants</p><p>Subtypes: Quaternary Ammonium Compounds, Alcohols, Chlorine Compounds, Peracetic Acid, and others</p><p>Sanitizers</p><p>Subtypes: Alcohol-based, Non-alcohol-based (Chlorine, Iodophors, etc.)</p><p>
<strong>By Form</strong></p><p>
</p><p><strong>Liquid Formulations Dominate Due to Ease of Application and Broad Coverage</strong></p><p>
</p><p>The market is segmented based on form into:</p><p>
</p><p>Liquids</p><p>Sprays</p><p>Wipes</p><p>Foams</p><p>Gels</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Hospital Segment Accounts for Largest Share Due to High Infection Control Requirements</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Hospitals</p><p>Subtypes: Surface disinfection, Instrument sterilization, Hand hygiene</p><p>Diagnostic Laboratories</p><p>Ambulatory Care Centers</p><p>Pharmaceutical &amp; Biotechnology Companies</p><p>Others</p><p>
<strong>By Composition</strong></p><p>
</p><p><strong>Chemical-based Products Lead the Market Given Their Proven Efficacy Against Pathogens</strong></p><p>
</p><p>The market is segmented based on composition into:</p><p>
</p><p>Chemical-based</p><p>Bio-based</p><p>Plant-based</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Market Leaders Accelerate Innovation to Meet Evolving Healthcare Hygiene Demands</strong></p><p>
</p><p>The global healthcare disinfectant and sanitizer market remains highly dynamic, with a mix of established multinational corporations and emerging regional players competing for market share. <strong>3M Company</strong> maintains its dominant position, controlling approximately 15% of the global market in 2024 through its diverse product portfolio spanning surface disinfectants, hand sanitizers, and surgical antiseptics. The company's continued investment in EPA-approved formulations and hospital-grade solutions has solidified its leadership.</p><p>
</p><p><strong>Ecolab Inc.</strong> and <strong>STERIS plc</strong> have emerged as formidable competitors, collectively accounting for nearly 22% of market revenue. Their growth stems from strategic acquisitions and development of proprietary technologies like Ecolab's Peracetic Acid-based disinfectants and STERIS's hydrogen peroxide vapor systems. Both companies have demonstrated particular strength in the hospital segment, where infection control standards continue to escalate post-pandemic.</p><p>
</p><p>Mid-tier players such as <strong>GOJO Industries</strong> (maker of Purell) and <strong>Reckitt Benckiser</strong> (Lysol) are adapting to market shifts by expanding into specialized healthcare formulations while maintaining strong consumer brand recognition. These companies are investing heavily in R&amp;D to develop alcohol-free and sustainable alternatives, responding to growing environmental concerns in the healthcare sector.</p><p>
</p><p>Meanwhile, <strong>Kimberly-Clark Professional</strong> and <strong>Cardinal Health</strong> are leveraging their existing distribution networks in healthcare facilities to gain market share. Their bundled solutions approach, combining disinfectants with complementary medical supplies, provides a competitive edge in cost-sensitive markets.</p><p>
<strong>List of Key Healthcare Disinfectant and Sanitizer Companies</strong></p><p>
</p><p>3M Company (U.S.)</p><p>Ecolab Inc. (U.S.)</p><p>STERIS plc (U.K.)</p><p>GOJO Industries, Inc. (U.S.)</p><p>Reckitt Benckiser Group plc (U.K.)</p><p>The Clorox Company (U.S.)</p><p>Kimberly-Clark Professional (U.S.)</p><p>Cardinal Health, Inc. (U.S.)</p><p>Medline Industries, Inc. (U.S.)</p><p>Procter &amp; Gamble (U.S.)</p><p>
</p><p>
<strong>HEALTHCARE DISINFECTANT AND SANITIZER MARKET TRENDS</strong></p><p>
<strong>Post-Pandemic Hygiene Awareness Drives Sustained Market Growth</strong></p><p>
</p><p>The global healthcare disinfectant and sanitizer market continues to experience robust growth, driven by enduring hygiene consciousness following the COVID-19 pandemic. While the initial surge in demand has stabilized, behavioral changes in infection prevention practices have created lasting market expansion. Healthcare facilities now maintain 30-40% higher consumption levels of disinfectants compared to pre-pandemic volumes, with particular growth in high-touch surface disinfectants and hand hygiene products. The market is further propelled by stricter regulatory requirements for healthcare-acquired infection (HAI) prevention, with many countries implementing more rigorous disinfection protocols in clinical settings.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Eco-Friendly Formulations Gain Traction</strong></p><p>
</p><p>Sustainability has emerged as a key differentiation factor, with healthcare facilities increasingly adopting green-certified disinfectants that balance efficacy with environmental responsibility. Alcohol-free sanitizers utilizing benzalkonium chloride and hydrogen peroxide-based disinfectants are witnessing 15-20% annual growth in adoption rates. This shift responds to both environmental concerns and workplace safety considerations, as traditional formulations often contain volatile organic compounds that can affect indoor air quality and staff health.</p><p>
<strong>Technological Innovations in Application Systems</strong></p><p>
</p><p>The market is seeing accelerated adoption of automated disinfection technologies, particularly in high-risk healthcare environments. Electrostatic sprayers, UV-C disinfection robots, and no-touch sanitizer dispensing systems are becoming standard in many hospitals, with some facilities reporting 30-50% reductions in surface contamination after implementation. These technologies complement traditional liquid disinfectants, creating hybrid disinfection protocols that enhance overall effectiveness. The integration of IoT sensors in sanitizer dispensers for usage monitoring and predictive refilling represents another significant advancement, optimizing both cost efficiency and compliance.</p><p>

<strong>Regional Analysis: Healthcare Disinfectant and Sanitizer Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
North America dominates the healthcare disinfectant and sanitizer market, accounting for over 35% of global revenue as of 2024. The U.S. leads regional consumption due to stringent infection control protocols from CDC, FDA, and EPA. Post-pandemic, healthcare facilities maintain elevated disinfection standards, with hospitals spending approximately $8.5 billion annually on IPC products. Canada shows accelerated growth through its Infection Prevention and Control Canada (IPAC) guidelines. The region is shifting toward sustainable formulations â projected to capture 45% market share by 2032 â driven by environmental regulations like California's Proposition 65 and consumer demand for non-toxic alternatives. Market leaders like Ecolab and 3M continue innovating with hydrogen peroxide-based disinfectants and alcohol-free sanitizers catering to sensitive healthcare environments.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe's market is characterized by rigorous EU biocidal product regulations (BPR) and a strong emphasis on green chemistry. Germany and France collectively contribute 52% of regional sales, with quaternary ammonium compounds remaining prevalent in hospital disinfection. The Nordic countries are spearheading adoption of UV disinfection systems as complementary technologies, growing at 14% CAGR. However, economic pressures have slowed capital investments in Eastern European healthcare facilities, creating a bifurcated market. Recent outbreaks of antimicrobial-resistant pathogens have reinvigorated demand for sporicidal disinfectants, particularly in the UK where National Health Service (NHS) standards mandate their use in surgical settings. The region is also witnessing consolidation among mid-sized manufacturers to meet rising compliance costs.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
APAC represents the fastest-growing market, projected to expand at 11.8% CAGR through 2032. China's healthcare disinfection market surpassed $2.3 billion in 2024, fueled by hospital expansion projects and tightened infection control policies post-COVID. India shows explosive demand in tier-2 cities where healthcare infrastructure is modernizing, though price sensitivity keeps chlorine-based disinfectants dominant. Japan maintains highest per-facility spending, with advanced oxidation process (AOP) technologies gaining traction in specialty hospitals. Southeast Asian markets face formulation challenges due to high humidity impacting product efficacy, driving innovation in stabilized hydrogen peroxide solutions. Australia's TGA regulations continue shaping product approvals across the region, creating opportunities for compliant international brands.</p><p>
</p><p><strong>South America</strong></p><p>
Brazil commands 60% of the regional market, where ANVISA regulations are elevating standards in public hospitals. The private healthcare sector drives premium product adoption, with alcohol-based hand sanitizer consumption growing 18% annually since 2020. Economic volatility in Argentina and Venezuela has disrupted supply chains, forcing hospitals to prioritize essential disinfectants over advanced formulations. Local manufacturers benefit from import substitution policies in Colombia and Peru, though foreign brands retain dominance in surgical site disinfection categories. Emerging concerns over antifungal-resistant Candida auris outbreaks are prompting revisions to national disinfection protocols across the region.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
GCC countries account for 70% of MEA market value, with UAE and Saudi Arabia implementing WHO-compliant disinfection standards across healthcare facilities. The region shows paradoxical trends â while liquid disinfectants dominate hospital procurement, foam and gel sanitizers lead in outpatient settings due to cultural handwashing preferences. Sub-Saharan Africa faces accessibility challenges; WHO estimates only 45% of healthcare facilities have reliable access to WHO-recommended disinfectants. South Africa remains the regional innovation hub, with several manufacturers developing chlorine-dioxide formulations suited to tropical conditions. Conflict zones continue straining infection control capacities, creating opportunities for humanitarian-focused product lines.</p><p></p><p><strong>Key Report Takeaways</strong></p><p></p><p>
</p><p>
</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Healthcare Disinfectant and Sanitizer, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Healthcare Disinfectant and Sanitizer companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Healthcare Disinfectant and Sanitizer Market?</strong></p><p>
</p><p><strong>-&gt;</strong> Global healthcare disinfectant and sanitizer market was valued at <strong>USD 6.94 billion in 2024</strong> and is projected to reach <strong>USD 12.48 billion by 2032</strong>, growing at a CAGR of 6.3%.</p><p>
<strong>Which key companies operate in Global Healthcare Disinfectant and Sanitizer Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>3M, Kimberly-Clark, Reckitt Benckiser, Ecolab, The Clorox Company, STERIS, GOJO Industries, and Cardinal Health</strong>, among others. These companies collectively hold over 65% of the market share.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising healthcare-associated infections (affecting 7% of hospitalized patients), increasing surgical procedures, and stringent hygiene regulations in healthcare facilities</strong>. The COVID-19 pandemic has accelerated adoption with 42% growth in demand during 2020-2022.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; North America</strong> accounted for 38% of global market share in 2024, while <strong>Asia-Pacific</strong> is projected to grow at the highest CAGR of 8.1% through 2032 due to expanding healthcare infrastructure.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>eco-friendly formulations, automated disinfection systems, and antimicrobial coatings</strong>. Recent innovations include hydrogen peroxide-based disinfectants with 30-second kill times against multi-drug resistant organisms.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/228419/healthcare-disinfectant-and-sanitizer-market">
            https://www.24chemicalresearch.com/reports/228419/healthcare-disinfectant-and-sanitizer-market</a></b></div><br>
            <b>Table of Content:</b><p>1 Introduction to Research & Analysis Reports<br />
    1.1 Healthcare Disinfectant and Sanitizer Market Definition<br />
    1.2 Market Segments<br />
        1.2.1 Market by Type<br />
        1.2.2 Market by Application<br />
    1.3 Global Healthcare Disinfectant and Sanitizer Market Overview<br />
    1.4 Features & Benefits of This Report<br />
    1.5 Methodology & Sources of Information<br />
        1.5.1 Research Methodology<br />
        1.5.2 Research Process<br />
        1.5.3 Base Year<br />
        1.5.4 Report Assumptions & Caveats<br />
2 Global Healthcare Disinfectant and Sanitizer Overall Market Size<br />
    2.1 Global Healthcare Disinfectant and Sanitizer Market Size: 2022 VS 2030<br />
    2.2 Global Healthcare Disinfectant and Sanitizer Revenue, Prospects & Forecasts: 2018-2030<br />
    2.3 Global Healthcare Disinfectant and Sanitizer Sales: 2018-2030<br />
3 Company Landscape<br />
    3.1 Top Healthcare Disinfectant and Sanitizer Players in Global Market<br />
    3.2 Top Global Healthcare Disinfectant and Sanitizer Companies Ranked by Revenue<br />
    3.3 Global Healthcare Disinfectant and Sanitizer Revenue by Companies<br />
    3.4 Global Healthcare Disinfectant and Sanitizer Sales by Companies<br />
    3.5 Global Healthcare Disinfectant and Sanitizer Price by Manufacturer (2018-2023)<br />
    3.6 Top 3 and Top 5 Healthcare Disinfectant and Sanitizer Companies in Global Market, by Revenue in 2022<br />
    3.7 Global Manufacturers Healthcare Disinfectant and Sanitizer Product Type<br />
    3.8 Tier 1, Tier 2 and Tier 3 Healthcare Disinfectant and Sanitizer Pl</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/228419/healthcare-disinfectant-and-sanitizer-market">
            https://www.24chemicalresearch.com/reports/228419/healthcare-disinfectant-and-sanitizer-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>